Opportunity Information: Apply for CDC RFA GH15 151503CONT17
Apply for CDC RFA GH15 151503CONT17
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthen the Capacity of Republican Narcology Centers on Practical Applications of Medication-Assisted Treatment Programs in the Kazakhstan, Kyrgyzstan and Tajikistan under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Sep 16, 2016.
- Applicants must submit their applications by Nov 21, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health, focused on strengthening the capacity of Republican Narcology Centers in Kazakhstan, Kyrgyzstan, and Tajikistan to improve the practical application of medication-assisted treatment (MAT) programs under the President's Emergency Plan for AIDS Relief (PEPFAR). The overall aim is to support and expand effective, evidence-based services for people with opioid use disorder in ways that also reduce HIV risk and improve HIV-related outcomes, reflecting PEPFAR's broader public health goals in regions where injection drug use can be a significant driver of HIV transmission.
The funding opportunity is identified as "Strengthen the Capacity of Republican Narcology Centers on Practical Applications of Medication-Assisted Treatment Programs in the Kazakhstan, Kyrgyzstan and Tajikistan under the President's Emergency Plan for AIDS Relief (PEPFAR)" with the funding opportunity number CDC RFA GH15-151503CONT17. It is categorized as continuation funding, meaning it is intended to continue or extend an existing project rather than launch a brand-new competitive initiative. The funding instrument is a cooperative agreement, which generally indicates that CDC will have substantial involvement in the work beyond simply providing funds, such as participating in planning, providing technical input, helping shape implementation approaches, and monitoring progress and results.
The activity category is health, and the listed CFDA number is 93.067, which corresponds to CDC global HIV/AIDS-related assistance. The opportunity anticipates a single award (ExpectedAwards: 1), suggesting the scope is designed for one main implementing partner or recipient to carry out the work across the target countries or to coordinate closely with country-level counterparts. The award ceiling is listed as 0, which in federal postings often means the ceiling is not specified in the notice and may be determined by the continuation award amount, available appropriations, or internal CDC/PEPFAR planning decisions rather than a fixed maximum disclosed upfront.
The target institutions are Republican Narcology Centers, which in many post-Soviet health systems function as specialized state-run services responsible for diagnosing and treating substance use disorders, including opioid dependence. The focus on "practical applications" of MAT signals an emphasis not just on policy discussions or high-level strategy, but on real-world clinical implementation: building provider competencies, strengthening service delivery models, improving adherence to treatment protocols, ensuring patient-centered care practices, and supporting the operational systems needed for MAT to work reliably (such as patient follow-up, coordination with HIV services, and consistent program management). In PEPFAR contexts, MAT is commonly understood as a key component of comprehensive prevention and treatment for people who inject drugs, because effective treatment for opioid use disorder can reduce injection frequency and related risk behaviors, and can improve engagement and retention in HIV prevention, testing, and care.
Because this is a cooperative agreement under PEPFAR, the project would typically align with core PEPFAR principles such as data-driven decision-making, quality improvement, linkage and retention in care, and integration across services where appropriate. In practice, capacity-strengthening activities under an award like this often include training clinicians and counselors, developing or updating clinical guidelines and standard operating procedures, mentoring and supportive supervision, improving monitoring and evaluation systems, and strengthening referral pathways between narcology services and HIV-related services (for example HIV testing, antiretroviral therapy programs, and prevention services). The grant title also implies a regional focus spanning Kazakhstan, Kyrgyzstan, and Tajikistan, which may involve harmonizing approaches across countries while adapting to each country's regulatory environment, health system structure, and existing MAT coverage.
Eligibility is listed broadly as "Others," with a note to consult the full announcement text for additional eligibility details. That typically means eligibility may be limited to a specific set of organizations (for example, existing recipients, certain types of institutions, or entities meeting particular requirements), which is consistent with the continuation nature of the award. The opportunity was created on September 16, 2016, with an original closing date of November 21, 2016, indicating the application window was a little over two months.
In short, this CDC PEPFAR continuation cooperative agreement is designed to reinforce and improve the implementation capacity of national-level narcology institutions in three Central Asian countries so they can deliver medication-assisted treatment more effectively and consistently, with the broader public health intent of reducing harms associated with opioid use, supporting HIV prevention goals, and strengthening the quality and sustainability of MAT service delivery within the existing health system.
FAQs: CDC Cooperative Agreement (PEPFAR) for Strengthening Medication-Assisted Treatment (MAT) Capacity in Central Asia
What is the name of this funding opportunity?
The opportunity is titled "Strengthen the Capacity of Republican Narcology Centers on Practical Applications of Medication-Assisted Treatment Programs in the Kazakhstan, Kyrgyzstan and Tajikistan under the President's Emergency Plan for AIDS Relief (PEPFAR)."
What is the funding opportunity number?
The funding opportunity number is CDC RFA GH15-151503CONT17.
Which U.S. agency is offering this opportunity?
This is offered by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Center for Global Health.
Is this a new competitive grant or a continuation award?
This is continuation funding, meaning it is intended to continue or extend an existing project rather than start a brand-new competitive initiative.
What type of funding instrument is being used?
The funding instrument is a cooperative agreement.
What does a cooperative agreement typically imply about CDC's role?
A cooperative agreement generally means CDC will have substantial involvement beyond providing funds, such as participating in planning, providing technical input, helping shape implementation approaches, and monitoring progress and results.
What program framework is this grant associated with?
The work is under the President's Emergency Plan for AIDS Relief (PEPFAR), and the grant is intended to support broader public health goals related to HIV prevention and HIV-related outcomes.
What is the main goal of the opportunity?
The overall aim is to strengthen the capacity of Republican Narcology Centers in Kazakhstan, Kyrgyzstan, and Tajikistan to improve the practical application of medication-assisted treatment (MAT) programs, in ways that reduce HIV risk and improve HIV-related outcomes.
Which countries are included in the scope of work?
The opportunity focuses on Kazakhstan, Kyrgyzstan, and Tajikistan.
Who are the target institutions for capacity strengthening?
The target institutions are Republican Narcology Centers, which are specialized state-run services in many post-Soviet health systems responsible for diagnosing and treating substance use disorders, including opioid dependence.
What is the activity category for this opportunity?
The activity category is health.
What is the CFDA number listed for this opportunity?
The CFDA number is 93.067, which corresponds to CDC global HIV/AIDS-related assistance.
How many awards are expected?
The opportunity anticipates a single award (ExpectedAwards: 1).
What does it mean that only one award is expected?
It suggests the scope is designed for one main implementing partner or recipient to carry out the work across the target countries, or to coordinate closely with country-level counterparts.
What is the award ceiling (maximum funding amount)?
The award ceiling is listed as 0, which in federal postings often indicates the ceiling is not specified in the notice and may be determined by continuation award amounts, available appropriations, or internal CDC/PEPFAR planning decisions rather than a fixed maximum disclosed upfront.
What does "practical applications" of MAT mean in this context?
It indicates a focus on real-world clinical implementation rather than only high-level strategy. This can include strengthening provider competencies, service delivery models, adherence to treatment protocols, patient-centered care practices, and the operational systems needed for reliable MAT delivery.
How does MAT relate to HIV prevention and HIV outcomes under PEPFAR?
In PEPFAR contexts, MAT is commonly treated as a key component of comprehensive prevention and treatment for people with opioid use disorder, because effective treatment can reduce injection frequency and related risk behaviors and can improve engagement and retention in HIV prevention, testing, and care.
What kinds of activities are typically included in a capacity-strengthening project like this?
Capacity-strengthening activities often include training clinicians and counselors, developing or updating clinical guidelines and standard operating procedures, mentoring and supportive supervision, improving monitoring and evaluation systems, and strengthening referral pathways between narcology services and HIV-related services (such as HIV testing, antiretroviral therapy programs, and prevention services).
Does the opportunity mention integration with HIV services?
Yes. It describes strengthening coordination and referral pathways between narcology services and HIV-related services, including testing, treatment programs, and prevention services.
How does this opportunity address data and quality improvement expectations?
Because it is under PEPFAR and structured as a cooperative agreement, the work would typically align with core PEPFAR principles such as data-driven decision-making, quality improvement, linkage and retention in care, and integration across services where appropriate.
Does the opportunity suggest regional coordination across the three countries?
Yes. The regional focus implies coordinating or harmonizing approaches across Kazakhstan, Kyrgyzstan, and Tajikistan while adapting to each country's regulatory environment, health system structure, and existing MAT coverage.
What is listed for eligibility?
Eligibility is listed broadly as "Others," with a note to consult the full announcement text for additional eligibility details.
Why might eligibility be listed as "Others" for this opportunity?
That kind of eligibility label often indicates eligibility may be limited to a specific set of organizations (such as existing recipients or specific institution types), which is consistent with the continuation nature of the award.
When was this opportunity created?
The opportunity was created on September 16, 2016.
What was the original closing date for applications?
The original closing date was November 21, 2016.
How long was the application window based on the dates provided?
Based on the creation date (September 16, 2016) and closing date (November 21, 2016), the application window was a little over two months.
What public health problem is this opportunity trying to address?
It focuses on improving services for people with opioid use disorder and reducing harms linked to opioid use, with an explicit emphasis on reducing HIV risk and improving HIV-related outcomes in settings where injection drug use can be a significant driver of HIV transmission.
What is the intended long-term impact described for this project?
The intent is to strengthen the quality and sustainability of MAT service delivery within existing health systems, while supporting HIV prevention goals and improved HIV outcomes.
Browse more opportunities from the same category: Health
Next opportunity: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01)
Previous opportunity: Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 151503CONT17
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 151503CONT17) also looked into and applied for these:
| Funding Opportunity |
|---|
| Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01) Apply for RFA RM 16 022 Funding Number: RFA RM 16 022 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $400,000 |
| Data Integration and Analysis Tools: Accessible Resources for Integration and Analysis of Carbohydrate and Glycoconjugate Data in the Context of Comparable Gene, Protein, and Lipid Data (U01) Apply for RFA RM 16 021 Funding Number: RFA RM 16 021 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Technical Assistance Services to Countries Supported by the President’s Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 136804CONT17 Funding Number: CDC RFA GH13 136804CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of the Republican AIDS Center to Implement HIV Program in the Republic of Tajikistan under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 151403CONT17 Funding Number: CDC RFA GH15 151403CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| R40 Autism Field-Initiated Innovative Research Studies (Autism-FIRST) Program Apply for HRSA 17 013 Funding Number: HRSA 17 013 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Autism Single Investigator Innovation Program (Autism-SIIP) Apply for HRSA 17 014 Funding Number: HRSA 17 014 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening Laboratory and Blood Transfusion Services in South Sudan under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 157103CONT17 Funding Number: CDC RFA GH15 157103CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Technical Assistance Support for the Strengthening of Blood Transfusion Services in Selected Countries Under PEPFAR Apply for CDC RFA GH12 125505CONT17 Funding Number: CDC RFA GH12 125505CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Centers of Excellence in Genomic Science (CEGS) (RM1) Apply for PAR 16 436 Funding Number: PAR 16 436 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| USAID Regional Health Integration to Enhance Services in Eastern Uganda Apply for RFA 617 16 000007 Funding Number: RFA 617 16 000007 Agency: Agency for International Development, Uganda USAID-Kampala Category: Health Funding Amount: $65,000,000 |
| Strengthen capacity of the South African Government’s Department of Health to provide quality and sustainable clinical care for HIV-infected patients with complicated HIV and HIV/TB treatment management, including 2nd and 3rd line and other antiret Apply for CDC RFA GH13 133504CONT17 Funding Number: CDC RFA GH13 133504CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Scaling up Voluntary Medical Male Circumcision through improvements in the availability, integration and quality of HIV prevention, care and treatment services in Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 132805CONT17 Funding Number: CDC RFA GH13 132805CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Expansion of HIV/AIDS Care and prevention among Church Related Hospitals and clinics in the Republic of Zimbabwe under the President?s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 133004CONT17 Funding Number: CDC RFA GH13 133004CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening of the Human Resources Information System and Development of Open Health Information Enterprise Architecture in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 160403CONT17 Funding Number: CDC RFA GH15 160403CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 159402CONT17 Funding Number: CDC RFA GH15 159402CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Engaging local indigenous organizations in developing HIV/AIDS monitoring and evaluation capacity in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 122805CONT17 Funding Number: CDC RFA GH12 122805CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Engaging local indigenous organizations in developing HIV/AIDS monitoring and evaluation capacity in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 122705CONT17 Funding Number: CDC RFA GH12 122705CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening the Healthcare System of Vietnam through Capacity Building, Policy Development and Quality Improvement of Laboratory and Clinical Services under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 159603CONT17 Funding Number: CDC RFA GH15 159603CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Partnering with Pasteur Institute of Ho Chi Minh City to Enhance Regional Capacity to Prevent, Detect, Monitor, and Respond to the HIV/AIDS Epidemic in Vietnam under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 159503CONT17 Funding Number: CDC RFA GH15 159503CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Partnering with Hanoi Medical University to Build Capacity and Implement Program Evaluation and Health System Strengthening in the Socialist Republic of Vietnam Under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 123205CONT17 Funding Number: CDC RFA GH12 123205CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 151503CONT17", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.